Preferences help
enabled [disable] Abstract
Number of results
2019 | 22 | 62-74
Article title

Extended Spectrum Beta Lactamase (ESBL) producing enteric bacteria from hospital wastewater, Ibadan, Nigeria

Title variants
Languages of publication
This study was conducted to investigate the occurrence of antibiotic resistance, including β-lactamase and extended spectrum β-lactamase production among enteric bacteria isolated from hospital wastewater from selected hospital within Ibadan. Physico-chemical analysis of hospital wastewater samples was done, enteric bacteria were isolated and identified using convectional biochemical tests while the selection of potential ESBL-producing bacteria was carried out using disc diffusion method and ESBL detection using double synergy test. The turbidity of the wastewater samples ranged between 4.45-6.5 NTU and total suspended solids ranged between 3.4- 45.5 mg/L. While electrical conductivity was between114.25-214 µs/m, the biological oxygen demand was between 25.8-31.25 mg/L and chemical oxygen demand ranged between 41.25-45.38 mg/L. Of the 200 bacteria isolated 35(17.5%) produced ESBL; 14(40%) from the tertiary hospital and 21(60%) from private hospital out of which 85.7%, 80% and 65.7% showed resistance to sulphamethxazole/Trimetoprim, streptomycin and tetracycline respectively, while resistance to meropenem (8.6%) was low. Among the ESBL-producing isolates, K. pneumonia had the highest (15(42.8%) rate of occurrence. This study revealed a need for hospital wastewater to be properly treated before discharged into water bodies and the environment to forestall the indiscriminate discharge of wastewater harbouring ESBL-producing bacteria.
Physical description
  • Department of Microbiology, University of Ibadan, Ibadan, Nigeria
  • Department of Microbiology, University of Ibadan, Ibadan, Nigeria
  • [1] Akpaka PE, Swanston WH. Phenotypic Detection and Occurrence of Extended-Spectrum Beta-Lactamases in Clinical Isolates of Klebsiella pneumoniae and Escherichia coli at a Tertiary Hospital in Trinidad & Tobago. Braz J Infec Dis 2008; 12 (6):516-520
  • [2] Al-Ahmad A, Daschner FD, Kümmerer K. Biodegradability of cefotiam, ciprofloxacin, meropenem, penicillin G, and sulfamethoxazole and inhibition of wastewater bacteria. Arch Environ Cont Toxic. 1999: 37: 158-163.
  • [3] APHA. Standard Methods for the Examination of Water and Wastewater. 21st Edition, American Public Health Association. Washington, 2005: p. 6710.
  • [4] Brooks L, Shaw A, Sharp D, Hay AD. Towards a better understanding of patients’ persectives of antibiotic resistance and MRSA: a qualitative study. Fam pract. 2005; 25: 341-348.
  • [5] Chitnis V, Chitnis DS, Patil S, Kant R. Hospital Effluent: A Source of Multiple Drug Resistant Bacteria. Curr Sci 2000; 79: 989-991.
  • [6] Clinical and Laboratory Standards Institute (CLSI). Performance Standards for Antimicrobial Susceptibility Testing. 27th ed. CLSI supplement M100. Wayne, PA: 2017.
  • [7] Dalela G. Prevalence of ESBL Producers among Gram Negative Bacilli from various Clinical Isolates in a Tertiary Care Hospital at Jhalawar, Rajasthan. Ind J Clin Diag Res. 2012; 6(2): 182-187
  • [8] Egbule, OS. Detection and Transfer of Extended Spectrum Beta Lactamase Enzymes from Untreated Hospital Waste Water. Adv Microbiol. 2016; 6: 512-520.
  • [9] Falodun OI, Ajala FA. Physicochemical studies of environmental samples and antimicrobial susceptibility profile of Escherichia coli isolated from Akinyele abattoir, Ibadan, Nigeria. J Appl Life Sci Int 2018; 17(2): 1-8
  • [10] Falodun OI, Morakinyo YM, Fagade OE. Determination of water quality and detection of extended beta-lactamase producing gram-negative bacteria in selected rivers located in Ibadan, Nigeria. Jord J Biol Sci. 2018; 11(1): 107-112
  • [11] FEPA. National Guideline and Standards for Industrial Effluents.Gaseous Emissions and Hazardous Waste Management in Nigeria. Federal Environmental Protection Agency, Lagos, Nigeria.
  • [12] Grabow W, Prozesky O. Drug resistance of coliform bacteria in hospital and city sewage. Antimicr Ag Chemoth 1973; 3:175-180.
  • [13] Hermansson M, Jones GW, Kjelleberg S. Frequency of antibiotic and heavy metal resistance, pigmentation and plasmids in bacteria of the marine air-water interface. Appl J Environ Microbiol 1987; 53: 2338-2342.
  • [14] Herwig RP Gray JP, Weston DP. Antibacterial resistant bacteria in surficial sediments near salmon net-cage farms in Puget Sound, Washington. Aquacul. 1997; 149: 263-283.
  • [15] Iversen A, Kühn I, Franklin A, Möllby R. High prevalence of vancomycin resistant enterococci in Swedish wastewater. Appl Environ Microbiol 2002; 68: 2838-2842.
  • [16] Jarlier V, Nicolas M.H, Fournier G, Philippon A. ESBLs conferring transferable resistance to newer-lactam agents in Enterobacteriaceae: Hospital prevalence and susceptibility patterns. Rev Infect Dis. 1998; 10: 867-878.
  • [17] Kuzucu C, Yetkin F, Gorgee S, Ersoy Y. 2011. Investigation of the susceptibilities of extended-spectrum beta-lactamase producing Escherichia coli and Klebsiellas spp. strains to ertapenem and other carbapenems. Microbiol bull. 45(1): 28-35.
  • [18] Magiorakos, AP, Srinivasan A, Carey RB, Carmeli Y, Falagas ME, Giske GG, Harbarth S, Hindler JF, Kahlmeter G, Olsson-Lilhequist B, Paterson DL, Rice LB, Stelling J, Struelens MJ, Vatopoulos A, Weber JT, Monnet DL. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect 2012, 18 (3), 268-81, DOI: 10.1111/j.1469-0691.2011.03570.x
  • [19] Maina D, Paul, Andrew N, Gunturu R. Antimicrobial resistance patterns in extended spectrum beta lactamase producing Escherichia coli and Klebsiella pneumonia isolates in a private tertiary hospital, Kenya. ISSN 2052-6180. 2013.
  • [20] Majlesi Nasr M, Yazdanbakhsh AR. Study on wastewater treatment systems in hospitals of Iran. Iran J Environ Health Sci Eng 2008; 5(3): 211-15.
  • [21] Mansouri S, Abbasi S. Prevalence of Multiple Drug Resistant Clinical Isolates of Extended-Spectrum Beta-Lactamase Producing Enterobacteriaceaein Southeast Iran. Iran J Med Sci 2010; 35 (2): 101
  • [22] Nasreen M, Sarker A, Malek MA, Ansaruzzaman MD, Rahman M. Prevalence and resistance pattern of Pseudomonas aeruginosa isolated from surface water. Adv Microbiol 2015; 5: 74-81.
  • [23] Paterson DL, Bonomo, RA. Extended spectrum β-lactamases: Clinical update. Clinical Microbiol Rev. 2005; 18(4): 657-686.
  • [24] Pfaller MA, Segreti J. Overview of the epidemiological profile and laboratory detection of extended-spectrum b-lactamases. Clinical Infectious Diseases 2006; 42: 153-163.
  • [25] Shakil S, Akram M, Ali SM, Khan AU. Acquisition of extended-spectrum-beta-lactamase producing Escherichia coli strains in Male and female infants admitted to a neonatal intensive care unit: molecular epidemiology and analysis of risk factors. J Med Microbiol 2010, 59: 948-954.
  • [26] SON. Standard Organization of Nigeria. Nigerian standard for drinking water quality. 2009; 15-16.
  • [27] Sridhar-Rao PN. Detection of extended spectrum beta-lactamase from clinical isolates in Davangere. Ind Jf Path Microbiol 2102; 51(4): 497-99.
  • [28] Stuart B. Factors impacting on the problem of antibiotic resistance. J Antimicrob Chemoth. 2002; 25-30.
  • [29] Umadevi S, Kandhakumari G, Joseph M, Kumar S, Easow JM, Stephen S. Prevalence and antimicrobial susceptibility pattern of ESBL producing gram negative bacilli. J Clin Diag Res 2011; 5(2): 236-239.
  • [30] WHO. Guidelines for the safe use of wastewater, excreta and gray water: Wastewater use in agriculture. Volume II. France: 2010. Pp. 222.
  • [31] Yang CM, Lin MF, Liao PC, Yeh HW, Chang, BV, Tang TK, Cheng C, Sung CH, Liou ML. Comparison of antimicrobial resistance patterns between clinical and wastewater strains in a regional hospital in Taiwan. Lett Appl Microbiol. 2009; 48: 560-565.
Document Type
Publication order reference
YADDA identifier
JavaScript is turned off in your web browser. Turn it on to take full advantage of this site, then refresh the page.